Generics Paulo Lilaia, CEO of Generis Portugal give an insight into the role of generics in the Portuguese marketplace as well as his company’s strategy to expand in both the local and international markets. You are both the President of Apogen and CEO of Generis. How do you balance your…
Generics Cristina Campos, CPO Head and Country President of Novartis Portugal talks about the challenges surrounding market access in Portugal, as well as the affiliate’s strong investments in the country to help alleviate the economic burden that is faced by all companies here. Between 2011 and 2012, the industry contributed €600…
R&D Nuno Arantes-Oliveira, President of P-BIO, Portugal’s Biotechnology Industry Organization, the country’s sole association for biotechnology companies, discusses the state of the biotech industry today in Portugal, and the ways in which the industry can consolidate and attract overseas investment to stimulate growth. After a harsh economic downturn over the…
Biotechnology Despite Portugal’s economic woes, some local companies have been able to adjust accordingly and succeed in this environment. Tecnifar is no exception. The company’s CEO, António Chaves Costa, talks about Tecnifar’s in-licensing strategy, as well as its diversification of investments and future plans for export business. Last year, Tecnifar…
medical tourism Joaquim Cunha, Executive Director of Health Cluster Portugal (HCP), emphasizes Portugal’s need to discover niches in which the country can excel and compete globally, while rebranding its image around the world. He also highlights the drivers behind cluster’s main initiatives: innovation, collaboration/coopetition and internationalization. What is Portugal’s number one…
Distribution Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and how they can be used as a competitive advantage in the healthcare landscape. Home to where the Zuellig Group…
MNCs Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in medical tourism. How do you expect further harmonization within the ASEAN region to affect the business climate in the Philippines?…
Array Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall by Cognizant, and what the future growth plans look like for the company’s next five years. Mr. Williams, you…
Generics Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines, stressing the need for local companies to raise brand awareness and not only target the private sector but partner with…
Array Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a common occurrence in the Philippines, and why she feels TTSI has a very bright and successful future ahead. From…
See our Cookie Privacy Policy Here
